This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Magellan's (MGLN) Unit Ties Up to Boost ASD Patient Outcomes
by Zacks Equity Research
Magellan Health's (MGLN) unit - Magellan Healthcare - collaborated with Invo Healthcare for improving the model that provides ABA treatment to autistic children.
Select Medical's (SEM) Growth Plans to Extend US Footprint
by Zacks Equity Research
Select Medical (SEM) undertakes a series of buyouts and JVs aimed to offer an array of long-term acute care services for treating the U.S. population.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Banking on its Acute Care and Behavioral Health platforms along with a robust capital position, Universal Health (UHS) holds potential to reap benefits for investors.
Humana's (HUM) Unit Unveils Centers for Serving South Louisiana
by Zacks Equity Research
Humana's (HUM) CenterWell brand introduces plans to open four centers offering enhanced healthcare services to South Louisiana's senior patients.
Here's Why Select Medical (SEM) is an Attractive Bet Now
by Zacks Equity Research
Select Medical's (SEM) northward analyst estimates and optimistic business prospects make it a lucrative stock to own for strong returns.
Magellan (MGLN) Unit Generates Cost Savings With Biosimilars
by Zacks Equity Research
Magellan's (MGLN) unit Magellan Rx benefits five health plan members, who utilized its oncology biosimilar solution. This generated annualized savings of more than $40 million for them.
Humana (HUM) Arm to Offer Original Medicare Members Holistic Care
by Zacks Equity Research
Humana's (HUM) CenterWell to provide value-based health care to Original Medicare beneficiaries.
Magellan Health's (MGLN) Q1 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) Q1 results reflect better performances by its Heathcare and Pharmacy Management segments.
Magellan Health (MGLN) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Magellan Health (MGLN) delivered earnings and revenue surprises of 70.51% and 0.52%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Magellan (MGLN) Expands in Precision Oncology With Trapelo
by Zacks Equity Research
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
Here's Why Hold Strategy is Apt for Centene (CNC) Stock
by Zacks Equity Research
Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.
Magellan Health (MGLN) Up 0.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Magellan Health (MGLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene (CNC) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Centene (CNC) and Humana (HUM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable based on fundamentals.
Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.
Humana (HUM) Joins IBM Watson Health to Aid Member Experience
by Zacks Equity Research
Humana (HUM) teams up with IBM Watson Health to leverage the latter's conversational AI solution for providing better information to Humana Employer Group members.
Magellan Health (MGLN), Wellth Tie Up on Behavioral Change
by Zacks Equity Research
Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.
Anthem's (ANTM) Buyout to Offer Better Healthcare in Puerto Rico
by Zacks Equity Research
Anthem (ANTM) acquires subsidiaries of InnovaCare Health in a bid to facilitate improved health outcomes across Puerto Rico.
Here's Why You Should Add Teladoc (TDOC) to Your Portfolio
by Zacks Equity Research
Teladoc (TDOC) has been benefiting from strong revenues, higher telehealth visits and robust cash balance.
Cigna (CI) to Gain From Integrated Benefits & Lower Costs
by Zacks Equity Research
Cigna (CI) reinforces the importance of integrated benefits, which has been reducing healthcare costs and resulting in improved health conditions.
Cigna (CI) Extends MA Network With Iora for Better Healthcare
by Zacks Equity Research
Cigna's (CI) MA network expands with the inclusion of Iora Health. The move intends to provide improved health outcomes for seniors.
ETFs to Gain on UnitedHealth and Change Healthcare Deal
by Sweta Killa
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
Molina Healthcare (MOH) Acquires Magellan Health's Unit
by Zacks Equity Research
Molina Healthcare (MOH) wraps up the buyout of Magellan Health's arm MCC to expand its presence and boost its capabilities.
Centene (CNC) to Buy Magellan Health for Better Medical Care
by Zacks Equity Research
Centene (CNC) to acquire Magellan Health for providing better healthcare to the most susceptible and underserved communities.
Company News for Jan 5, 2021
by Zacks Equity Research
Companies in The News are: HLF,MGLN,CNC,WKHS,FLIR,TDY
Cigna (CI) Divests to Deepen Focus on Healthcare, Repay Debt
by Zacks Equity Research
Cigna's (CI) sale of its non-health unit paves way for it to focus on its core business and make debt repayments.